Back to Companypage
Business Logo
 
  • Konzern
    • About us
    • Management
    • Press
    • Events
    • Employees
    • Careers
    • Sponsoring
  • Business Units
    • Analytical Instrumentation
    • Life Science
    • Optics
  • Produkte
    • Products from A to Z
  • Investor | Media Relations
    • Key Figures
    • Reports
    • Share
    • Information
    • Events
    • Press Center
Investor | Media Relations
  • Key Figures
  • Reports
  • Share
  • Information
  • Events
  • Press Center
    • Downloads

Analytik Jena Company

  • AJ Blomesystem
  • AJ Cybertron
  • AJ eBiochip
  • AJ Innuscreen
  • AJ Roboscreen
  • AJZ Engineering
  • Biometra GmbH
  • CyBio AG
  • DOCTER®
  • Analytik Jena Worldwide |
  • Languages
    • English
    • Deutsch
 

zurück zur Übersicht

Analytik Jena is starting into the business year again with increases in turnover and result.
Jena, February 13, 2007 – In the first quarter (10/01/06 – 12/31/06), the Analytik Jena Group reached a sales figure of EUR 17.952 million (previous year: 15.787).

Jena, February 13, 2007 - In the first quarter (10/01/06 - 12/31/06), the Analytik Jena Group reached a sales figure of EUR 17.952 million (previous year: 15.787). In result, the total revenue amounted to 13.7 % above the preceding year. The operating result of the group improved by 11.2 % to EUR 1.288 million (previous year: 1.158) against the preceding year. The improvements in the Group's balance sheet is basically due to the positive development in the instrumentation business.

Within the segment of instruments business, the sales figure of Analytik Jena increased in the reporting period by 22.6 % up to EUR 11.536 million (previous year: 9.413) compared with the preceding year.
In the first quarter, sales in the project business correspond to the level of the preceding year with EUR 6.416 million (previous year: 6.374).
With foreign sales of EUR 13.084 million (previous year: 10.885) the Group reported an exportation increase of four points to 72.9 %.

The gross margin of Analytik Jena increased to 42.0 % (previous year: 37.6%) as of the end of the first quarter.
The operating result (EBIT) grew by 11.2 % to EUR 1.288 million (previous year: 1.158). Related to the segments, Analytik Jena achieved an EBIT in the instruments business of EUR 1.299 million (previous year: 1.228) against the preceding year. This also includes the launching costs for the affiliate company AJ Japan which amount to nearly EUR 0.400 million. In the project business the group was able to show an equalized operative result with minus EUR 0.011 million (previous year: -0.070).
In total, the group realized a net income for the period of EUR 0.726 million (previous year: 0.564) in the first quarter of the financial year 2006/2007. This corresponds to an increase in profits of 28.7 %. Taking into account a growth of share equity by 962,501 shares in comparison to the preceding year, the earnings per share amounts to EUR 0.15 (previous year: 0.15).

As of December 31, 2006, the balance sheet total reduced to EUR 61.511 million (as at 09/30/06: EUR 63.607 million) compared to September 30, 2006. The equity ratio grew from 43.5 % to 47.6 %.
The cash of the Group amounts to EUR 11.662 million (as at 09/30/06: EUR 11.735 million) as of the end of the period.

For the coming financial year 2006/2007, Analytik Jena expects that the positive business development will continue. Current incoming orders in the instruments segment underscore this suggestion. Is spite of its first sales, the Company continues to assume that AJ Japan will burden the operating result of the second quarter too. Regarding project solutions, the Group management is expecting increases in sales figure and result only for the second half year.
Due to seasonal reasons, the Company is expecting a quite, but positive business operation for the current quarter.

Key figures:
 

3 months report

2006/2007

2005/2006

Total net sales

17.952

15.787

13.7 %

Export ratio

72.9 %

68.9 %

Gross margin

42.0 %

37.6 %

EBIT

1.288

1.158

11.2 %

EBIT to sales ratio

7.2 %

7.3 %

Net income for the period

726

564

28.7 %

Earnings per share

0.15

0.15

Personnel expenditure

4.588

3.779

21.4 %

Cash and cash equivalents

11.662

9.431

23.7 %

Equity

29.274

27.638

5.9 %

Total assets

61.511

63.607

-3.3 %

Equity ratio

47.6 %

43.5 %

Number of employees

520

452

15.0 %


in million EUR, with the exception of amounts per share and employees

Report for 3 months 06/07

 
AJ Blomesystem | AJ Cybertron | AJ eBiochip | AJ Innuscreen | AJ Roboscreen | AJZ Engineering | Biometra GmbH | CyBio AG | DOCTER®
© Analytik Jena AG | All rights reserved | Contact | Imprint | TOC | Disclaimer | Sitemap